These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
518 related articles for article (PubMed ID: 16172107)
1. Identification of a new antitubercular drug candidate, SQ109, from a combinatorial library of 1,2-ethylenediamines. Protopopova M; Hanrahan C; Nikonenko B; Samala R; Chen P; Gearhart J; Einck L; Nacy CA J Antimicrob Chemother; 2005 Nov; 56(5):968-74. PubMed ID: 16172107 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of SQ109 analogues as potential anti-tuberculosis candidates. Onajole OK; Govender P; van Helden PD; Kruger HG; Maguire GE; Wiid I; Govender T Eur J Med Chem; 2010 May; 45(5):2075-9. PubMed ID: 20149497 [TBL] [Abstract][Full Text] [Related]
3. Synergistic interactions of SQ109, a new ethylene diamine, with front-line antitubercular drugs in vitro. Chen P; Gearhart J; Protopopova M; Einck L; Nacy CA J Antimicrob Chemother; 2006 Aug; 58(2):332-7. PubMed ID: 16751637 [TBL] [Abstract][Full Text] [Related]
4. Thiosemicarbazones, semicarbazones, dithiocarbazates and hydrazide/hydrazones: anti-Mycobacterium tuberculosis activity and cytotoxicity. Pavan FR; da S Maia PI; Leite SR; Deflon VM; Batista AA; Sato DN; Franzblau SG; Leite CQ Eur J Med Chem; 2010 May; 45(5):1898-905. PubMed ID: 20163897 [TBL] [Abstract][Full Text] [Related]
5. Discovery of new 1,3,5-triazine scaffolds with potent activity against Mycobacterium tuberculosis H37Rv. Sunduru N; Gupta L; Chaturvedi V; Dwivedi R; Sinha S; Chauhan PM Eur J Med Chem; 2010 Aug; 45(8):3335-45. PubMed ID: 20452706 [TBL] [Abstract][Full Text] [Related]
6. Antimycobacterial terpenoids from Juniperus communis L. (Cuppressaceae). Gordien AY; Gray AI; Franzblau SG; Seidel V J Ethnopharmacol; 2009 Dec; 126(3):500-5. PubMed ID: 19755141 [TBL] [Abstract][Full Text] [Related]
7. Novel aryloxy azolyl chalcones with potent activity against Mycobacterium tuberculosis H37Rv. Marrapu VK; Chaturvedi V; Singh S; Singh S; Sinha S; Bhandari K Eur J Med Chem; 2011 Sep; 46(9):4302-10. PubMed ID: 21764184 [TBL] [Abstract][Full Text] [Related]
8. 2,3-dideoxy hex-2-enopyranosid-4-uloses as promising new anti-tubercular agents: design, synthesis, biological evaluation and SAR studies. Saquib M; Husain I; Sharma S; Yadav G; Singh VK; Sharma SK; Shah P; Siddiqi MI; Kumar B; Lal J; Jain GK; Srivastava BS; Srivastava R; Shaw AK Eur J Med Chem; 2011 Jun; 46(6):2217-23. PubMed ID: 21440336 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones. Castagnolo D; Manetti F; Radi M; Bechi B; Pagano M; De Logu A; Meleddu R; Saddi M; Botta M Bioorg Med Chem; 2009 Aug; 17(15):5716-21. PubMed ID: 19581099 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, structure, and antimycobacterial activity of 6-[1(3H)-isobenzofuranylidenemethyl]purines and analogs. Braendvang M; Bakken V; Gundersen LL Bioorg Med Chem; 2009 Sep; 17(18):6512-6. PubMed ID: 19709890 [TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo activities of a new lead compound I2906 against Mycobacterium tuberculosis. Lu J; Yue J; Wu J; Luo R; Hu Z; Li J; Bai Y; Tang Z; Xian Q; Zhang X; Wang H Pharmacology; 2010; 85(6):365-71. PubMed ID: 20530976 [TBL] [Abstract][Full Text] [Related]
12. Development of antitubercular compounds based on a 4-quinolylhydrazone scaffold. Further structure-activity relationship studies. Gemma S; Savini L; Altarelli M; Tripaldi P; Chiasserini L; Coccone SS; Kumar V; Camodeca C; Campiani G; Novellino E; Clarizio S; Delogu G; Butini S Bioorg Med Chem; 2009 Aug; 17(16):6063-72. PubMed ID: 19620006 [TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamics and pharmacokinetics of SQ109, a new diamine-based antitubercular drug. Jia L; Tomaszewski JE; Hanrahan C; Coward L; Noker P; Gorman G; Nikonenko B; Protopopova M Br J Pharmacol; 2005 Jan; 144(1):80-7. PubMed ID: 15644871 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of novel [1,2]-diamines with antituberculosis activity. Meng Q; Luo H; Chen Y; Wang T; Yao Q Bioorg Med Chem Lett; 2009 Sep; 19(18):5372-5. PubMed ID: 19682895 [TBL] [Abstract][Full Text] [Related]
15. Knowledge based identification of potent antitubercular compounds using structure based virtual screening and structure interaction fingerprints. Kumar A; Chaturvedi V; Bhatnagar S; Sinha S; Siddiqi MI J Chem Inf Model; 2009 Jan; 49(1):35-42. PubMed ID: 19063713 [TBL] [Abstract][Full Text] [Related]
16. Antimycobacterial activity of novel N-(substituted)-2-isonicotinoylhydrazinocarbothioamide endowed with high activity towards isoniazid resistant tuberculosis. Sriram D; Yogeeswari P; Yelamanchili Priya D Biomed Pharmacother; 2009 Jan; 63(1):36-9. PubMed ID: 18343086 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of (S,S)-N,N'-bis-[3-(2,2',6,6'-tetramethylbenzhydryloxy)-2-hydroxy-propyl]-ethylenediamine (S2824) analogs with anti-tuberculosis activity. Zhang X; Hu Y; Chen S; Luo R; Yue J; Zhang Y; Duan W; Wang H Bioorg Med Chem Lett; 2009 Nov; 19(21):6074-7. PubMed ID: 19796945 [TBL] [Abstract][Full Text] [Related]
18. Antitubercular activity of quinolizidinyl/pyrrolizidinylalkyliminophenazines. Tonelli M; Novelli F; Tasso B; Sparatore A; Boido V; Sparatore F; Cannas S; Molicotti P; Zanetti S; Parapini S; Loddo R Bioorg Med Chem; 2014 Dec; 22(24):6837-45. PubMed ID: 25464882 [TBL] [Abstract][Full Text] [Related]
19. Antituberculosis agents. VI. Activity of a new ciprofloxacin derivative against Mycobacterium avium and some drug-resistant strains of Mycobacterium tuberculosis. Foroumadi A; Soltani F; Moshafi MH Boll Chim Farm; 2002; 141(5):394-6. PubMed ID: 12481384 [TBL] [Abstract][Full Text] [Related]
20. Synthesis, in vitro and in vivo antimycobacterial activities of diclofenac acid hydrazones and amides. Sriram D; Yogeeswari P; Devakaram RV Bioorg Med Chem; 2006 May; 14(9):3113-8. PubMed ID: 16412646 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]